MARATTO

article · Ain Shams Journal of Surgery

How to Avoid and Manage Puncture Site Complications?.

Abstract

Introduction: Recently percutaneous transluminal angioplasty (PTA) using catheter-based interventions hasbecome the first-line option in the treatment of lower limb ischemia as it improves all patients’ symptoms with arelatively lower complication rate.Aim of work: Evaluation of puncture site complications, their incidence, management & how to avoid it.Results: This study was conducted on 163 patients with PAD, 99 (60.7%) males. Patients age ranged between44 to 87 years with a median of 63 years, 8 (4.9%) patients were complaining of severe claudication, 31 (19%)presented with ischemic rest pain, patients with minor & major tissue loss were 79 (48.4%) & 45 (27.6%)respectively. Sixteen patients had puncture site complications; hematoma 11 (6.14%), pseudoaneurysm (PSA) 3(1.6%), dissection 1 (0.56%) & 1 (0.56%) case with arteriovenous fistula. Patients ˃ 60 years & female genderhad a higher number of complications. Regarding puncture site complications management: 11 (68.75%) patientswere managed conservatively, 2 (12.5%) with U/S guided compression, 2 (12.5%) by open surgical repair and 1(6.25%) patient with low-pressure balloon inflation for 5 minutes.Conclusion: Puncture site complications could be avoided or reduced by risk assessment, meticulous puncturetechnique, usage of Doppler ultrasound and proper compression. It could be managed by minimally invasiveprocedures with good results, but surgery remains a role in difficult, resistant and complicated cases.

Research topics

  • Intramuscular injections and effects
  • Surgical site infection prevention
  • Nosocomial Infections in ICU

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/asjs.2024.368153

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.